[ Price : $8.95]
ReShape Lifesciences files a PMA supplement for the companys next generation Lap-Band 2.0 for long-term treatment of obesity.[ Price : $8.95]
FDA approves a Pfizer NDA for Litfulo (ritlecitinib), a once-daily oral treatment for individuals 12 years of age and older with s...[ Price : $8.95]
FDA extends its review of UCB's psoriasis drug bimekizumab for reasons the company did not disclose.[ Price : $8.95]
FDA clears a CS Medical 510(k) for its Ethos Automated Ultrasound Probe Cleaner Disinfector.[ Price : $8.95]
FDA lifts a Pharvaris clinical hold on a deucrictibant clinical trial for the on-demand treatment of hereditary angioedema attacks...[ Price : $8.95]
Citing potential liver injury concerns, Pfizer says it is terminating the development program for glucagon-like peptide-1 receptor...[ Price : $8.95]
CBER director Peter Marks overrides the review team in the 6/22 accelerated approval of Sarepta Therapeutics Duchenne muscular dys...[ Price : $8.95]
FDA posts a draft guidance entitled Psychedelic Drugs: Considerations for Clinical Investigations.